Furthermore, sialylated T-antigen was associated with an enhanced growth rate of mammary carcinoma cells in MUC1 transgenic mice [22] and with the malignancy of bladder cancer [23], ovarian cancer [24], and colorectal cancer [25] in humans. Here, MUC1 is linked to ovarian carcinoma.